Hypoparathyroidism secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Hypoparathyroidism}} | {{Hypoparathyroidism}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{DAMI}} | ||
==Overview== | ==Overview== |
Revision as of 11:40, 15 August 2017
Hypoparathyroidism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypoparathyroidism secondary prevention On the Web |
American Roentgen Ray Society Images of Hypoparathyroidism secondary prevention |
Risk calculators and risk factors for Hypoparathyroidism secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- There are no established measures for the secondary prevention of [disease name].
OR
- Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]